CONMED officer granted 5,896 RSUs

Pelletier Johonna Marie reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Pelletier Johonna Marie reported acquisition or exercise transactions in this Form 4 filing.

CONMED Corp reported that Treasurer and VP, Tax Johonna Marie Pelletier received a grant of 5,896 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of CONMED common stock under the 2025 Long-Term Incentive Plan.

The RSUs generally vest over three years, with 33% vesting one year after the grant date, another 33% in the second year, and the remaining 34% in the third year, encouraging multi‑year retention and alignment with shareholders.

Insider Trade Summary

Grant/Award: 5,896 shares

Grant/Award 1 txn

Insider Pelletier Johonna Marie

Role Treasurer and VP, Tax

Type	Security	Shares	Price	Value
Grant/Award	RSUs (Restricted Stock Units)	5,896	$0.00	$0.00

Holdings After Transaction: RSUs (Restricted Stock Units) — 5,896 contracts (Direct)

Footnotes (1)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CONMED Corp (CNMD) report for Johonna Marie Pelletier?

CONMED reported that Johonna Marie Pelletier received 5,896 RSUs. These restricted stock units are part of the company’s 2025 Long-Term Incentive Plan and give a contingent right to receive one CONMED common share per unit, subject to vesting conditions over three years.

How many RSUs were granted to the CONMED (CNMD) treasurer in the latest Form 4?

The CONMED treasurer was granted 5,896 RSUs. Each RSU corresponds to one share of CONMED common stock, subject to the plan’s terms and a three-year vesting schedule, which supports long-term retention and aligns compensation with company performance over time.

What is the vesting schedule for the 5,896 CONMED (CNMD) RSUs granted to Johonna Pelletier?

The 5,896 RSUs generally vest over three years. About 33% vest one year after the grant date, another 33% in the second year, and 34% in the third year, spreading ownership incentives across a multi‑year period for the executive.

Do CONMED (CNMD) RSUs granted in this Form 4 convert into common stock?

Each RSU represents a contingent right to receive one share of CONMED common stock. Actual share delivery depends on satisfying the vesting terms under the 2025 Long-Term Incentive Plan, meaning the units convert into shares over the defined three-year schedule.

Was the CONMED (CNMD) RSU grant to Johonna Pelletier a purchase or a compensation award?

The RSU transaction was a compensation award, not a market purchase. It is reported with transaction code “A” for a grant or award acquisition, reflecting equity-based compensation as part of CONMED’s 2025 Long-Term Incentive Plan rather than a cash-funded share buy.

What plan governs the RSUs granted to the CONMED (CNMD) treasurer?

The RSUs are governed by CONMED’s 2025 Long-Term Incentive Plan. This plan sets the terms and conditions for equity awards, including that the 5,896 RSUs vest in tranches of 33%, 33%, and 34% over a three-year period following the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 03:59 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pelletier Johonna Marie

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Treasurer and VP, Tax

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
RSUs (Restricted Stock Units)	$0	03/02/2026		A		5,896		(1)	03/02/2036	Common Stock	5,896	$0	5,896	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

	/s/ Thomas Fistek for Johonna M. Pelletier by Power of Attorney	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.